Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Herantis Pharma Announces Members of Scientific Advisory Board

Herantis Pharma Plc, Press Release, 25 October 2021 at 9:00 EEST Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases, today announced the formation of a Scientific Advisory Board (SAB) comprised of industry leaders in CNS and neurodegenerative diseases, chaired by Dr. Anders Gersel Pedersen (as announcment September 14, 2021). The SAB will work cohesively with management to advance the company’s clinical development plan of rhCDNF (recombinant human CDNF) and HER-096 (xCDNF). “The prestigious group of scientific thought

Kindred’s revenue from harmful gambling 3.3 per cent in the third quarter

Kindred is determined to contribute to a more sustainable gambling industry across all markets through an open and fact-based dialogue. In the third quarter of 2021, Kindred’s share of revenue from harmful gambling decreased to 3.3 per cent.Kindred Group plc (Kindred) is committed to transform gambling by being a trusted source of entertainment that contributes positively to society. Therefore, Kindred has set an ambition to reach zero per cent of revenue from harmful gambling by the end of 2023 and to report this on a quarterly basis. The purpose is to be transparent, contribute to a fact-

Nitro Games Oyj: Interim Report January – September 2021

Reporting period January – September 2021 · Revenues (Jan - Sep): 1 404,6 KEUR (1 085,5 KEUR). · EBITDA: -2 059,9 KEUR (-1 449,4 KEUR). · EBIT: -2 474,5 KEUR (-1 791,9 KEUR). · Net result: -2 490,5 KEUR (-1 806,8 KEUR). · Earnings per share (EPS) -0,2 (-0,2). · Cash and cash equivalents: 3 666,6 KEUR (30 September 2021). (Numbers in brackets refer to the corresponding year-on-year period) July – September 2021 · Revenues (Jul - Sep): 969,1 KEUR (100,8 KEUR). · EBITDA: -512,1 KEUR (-819,5 KEUR). · EBIT: -626,1 KEUR (-933,7 KEUR). · Net result: -633,7

Invitation to presentation of Bactiguard’s interim report on October 28, 2021

Bactiguard Holding AB (publ) publishes the interim report for the third quarter on Thursday October 28, 2021 at 8:00 CET.In connection with this, an audiocast for investors, analysts and media will be held at 10:00 CET on October 28. CEO Anders Göransson and CFO Gabriella Björknert Caracciolo will present the interim report and answer questions. The report and a presentation for the audiocast will be available at Bactiguard’s website https://www.bactiguard.com. To participate in the audiocast, please use this link: https://tv.streamfabriken.com/bactiguard-q3-2021 To participate only

Josefin Lindstrand leaves Swedbank’s Board of Directors

Josefin Lindstrand has notified that she will leave Swedbank’s Board of Directors to accept other board positions within the industry of financial technology and products.“Josefin Lindstrand has contributed in an excellent way to Swedbank’s considerable progress in leaving the historical AML-issues behind. I wish Josefin all the best in her new positions where I am convinced that her competence will prove itself very valuable,” says Göran Persson, Chair of Swedbank’s Board of Directors. Josefin Lindstrand who has served on Swedbank’s Board of Directors since 2019 leaves her position

Lancet’s EClinicalMedicine publishes phase 2 data on C21 in COVID-19

· The trial showed that C21 reduced the need for supplemental oxygen and mechanical ventilation, indicating faster patient recovery. C21 was also found to be safe and well tolerated. · Data encouraged Vicore to move into phase 3 with readout on-track for H1 2022.Gothenburg, October 25, 2021 - Vicore Pharma Holding AB (publ) (“Vicore”), a rare disease pharmaceutical company developing innovative medicines for severe lung disorders, today announces that the results of the COVID-19 phase 2 trial of its angiotensin II type 2 receptor agonist C21 have been published in EClinicalMedicine, a

Embellence Group Interim Report Q3 2021

Tentative demand during hot summer monthsThird quarter of 2021 · Net sales amounted to MSEK 135.5 (130.8), up 3.6% · Adjusted EBITA amounted to MSEK 18.3 (21.4), down 14.2% · EBITA amounted to MSEK 18.3 (21.2), down 13.4% · Net profit for the period amounted to MSEK 12.2 (12.7) and earningsper share before dilution for the period were SEK 0.57 (0.59) · Operating cash flow amounted to MSEK 16.1 (18.9) Significant events during the quarter · Robert Shams Smolander appointed Head of Group Change Management & Sustainability Significant events after the end of the

Yet another strong quarter

Financial highlights July – September 2021 · Net sales increased by 44.6 percent to EUR 34.3m (23.7). Organic growth excluding currency effects was 34.0 percent · Gross profit amounted to EUR 17.5m (12.0) with a gross margin of 50.9 percent (50.7) · Adjusted EBITDA amounted to EUR 6.6m (3.8) with an adjusted EBITDA margin of 19.4 percent (16.2). Adjusted EBITDA, excluding the FX effect from the revaluation of operating balance sheet items, amounted to EUR 5.9m (4.2) and the margin 17.2% (17.8) · Adjusted earnings per share, before and after dilution amounted to EUR 0.03 (0.

Rock Energy

After the recent name change to GET Group, an update from the group’s largest subsidiary Rock Energy is presented in a video that has now been published on our website getgroup.se today at 08:00 CET. GET Group is an investment company focused on energy and sustainability. We are creating the world’s most compelling listed ESG tech-company, by owning and financing the unique technology companies that are committed to energy production and energy saving. Link to video: Rock Energy 

GomSpace (provider of nanosatellites) announces its quarterly results for the third quarter 2021

Stockholm, October 25, 2021. GomSpace Group AB (the “Company”) announces its interim report for the third quarter of 2021. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report: Third quarter summary 1 July – 30 September 2021 (2020) · Order intake decreased to T.SEK 43,034 (136,472) · Net revenues increased to T.SEK 49,700 (39,136) · Gross margin decreased to 20% (24%) · Operating profit (loss) were a negative T.SEK 7,240 (a negative 7,234) · Earnings per share were a negative SEK 0.14 (a negative 0.14)

Hexagon Composites ASA: Invitation to presentation of third quarter results 2021

Hexagon Composites ASA’s third quarter results 2021 will be released on 4 November 2021, 07:00 CET. Jon Erik Engeset (CEO) and David Bandele (CFO) will present the results at 08:30 CET. The presentation will be held in the Auditorium at Hexagon’s location in Oslo, Haakon VIIs gate 2, on the lower level. As Covid-19 restrictions are lifted in Norway, we welcome those that want to attend the presentation in person. The presentation will also be broadcasted live via: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20211104_16.A recording of the presentation will be made

Dennis Andersson new CEO of Swedish Stirling

Clean-tech company Swedish Stirling AB (publ) carries out a CEO succession on 15 November 2021 when Dennis Andersson will become the new CEO. Dennis takes over a company that has successfully landed the first commercial agreements concerning its PWR BLOK-technology and that is entering into a clear industrialization phase.The board of Swedish Stirling has appointed Dennis Andersson as new CEO of the company. Dennis will take up the position on 15 November 2021. He is currently deputy CEO and Chief Marketing & Sales Officer of the company. He was hired by the company in June 2020 and came

Desentum reports positive findings for the First-in-Human clinical study of lead product candidate in birch pollen allergic adults

Desentum Oy, a clinical-stage biopharmaceutical company developing novel immuno­therapies for treating allergies, today announced positive First-in-Human clinical data of DM-101, its lead candidate for treatment of birch pollen allergy. DM-101 was found to be safe and well tolerated in a dose regimen of 5 ascending doses, and immunological marker results indicated a favourable immunological response.“We are very happy to have completed the clinical study despite the challenges posed by the Covid-19 pandemic. The preclinical models available for testing allergen immunotherapy products are

Skanska invests about SEK 450M in a new residential development project in Stockholm, Sweden

Skanska invests about SEK 450M in a new residential block with a total of 107 Nordic Swan ecolabelled apartments in Bromma, Stockholm, Sweden.The condominium project in Mariehäll consists of a total of three buildings. Water views and the proximity to Bällstaviken have been central to the design of both buildings, apartments, and courtyards. The courtyards, with a strong focus on greenery, offer natural meeting places for increased well-being in the area. The project is certified according to the Nordic Swan ecolabel, which means high demands on quality, environmental, energy and health

FY 2022 Q1 - Growth of 110% - full recovery in the market

SUMMARY FOR FINANCIAL YEAR 2022 Q1 Financial Highlights · Net sales in Q1 were SEK 21.2m, corresponding to a 110% increase compared with the same period in 2020 (SEK 10.1m). · Recurring revenues increased by 26%. Underlying organic sales growth on a proforma basis of 3.4%. · Normalised EBITDA (EBITDA before non-recurring items and FX translation) was SEK 0.9m compared to the same period in 2020 (SEK 2.4m). As we indicated at the beginning of the year, the company is investing for future growth which has led to the decrease in Normalised EBITDA. · EBITDA of SEK 0.0m

Report for the third quarter 2021: Another record quarter

The third quarter · Revenue was SEK 25,220 (14,481) million · EBITDA was SEK 6,582 (-66) million · Operating profit was SEK 5,800 (-973) million · Earnings per share were SEK 4.35 (-0.72)Comments by the CEO – continued strong earnings trend SSAB reports a continued strong earnings trend for Q3 2021. High steel prices in combination with a strong and stable internal performance saw us exceed the record in Q2, despite planned maintenance outages. During the quarter, SSAB made the world’s first fossil-free steel and delivered it to Volvo Group. We also signed a number of new

Invitation to presentation of Embellence Group’s interim report for the third quarter 2021

Embellence Group publishes the quarterly report for the third quarter (July to September) on October 25 at 08:00 CEST. In connection with the announcement, Embellence Group invites to a video conference on the same day, held at 10:00 CEST.The presentation will be held in English by Olle Svensk (CEO) and Pär Ihrskog (CFO). To attend, use the link  https://tv.streamfabriken.com/embellence-group-q3-2021 or dial in at SE: +46856642693 UK: +443333009274 US: +16467224903 Subscribe to reports and press releases:https://www.embellencegroup.com/newsroom/subscribe

Increased consumption of whole grains could significantly reduce the economic impact of type 2 diabetes

Increased consumption of whole grain foods could significantly reduce the incidence of type 2 diabetes and the costs associated with its treatment in Finland, according to a recent study by the University of Eastern Finland and the Finnish Institute for Health and Welfare. The findings were published in Nutrients.“Our study shows that already one serving of full grains as part of the daily diet reduces the incidence of type 2 diabetes at the population level and, consequently, the direct diabetes-related costs, when compared to people who do not eat whole grain foods on a daily basis. Over

Expansion of wind and solar power too slow to stop climate change

The production of renewable energy is increasing every year. But after analysing the growth rates of wind and solar power in 60 countries, researchers at Chalmers University of Technology and Lund University in Sweden and Central European University in Vienna, Austria, conclude that virtually no country is moving sufficiently fast to avoid global warming of 1.5°C or even 2°C. “This is the first time that the maximum growth rate in individual countries has been accurately measured, and it shows the enormous scale of the challenge of replacing traditional energy sources with

Axel Johnson International signs sustainability-linked loan with Swedish Export Credit Corporation (SEK)

Axel Johnson International increases its ambitions in sustainability and signs a sustainability-linked loan of 55 million euro with Swedish Export Credit Corporation (SEK). The loan is linked to several sustainability-related goals with focus on energy efficiency and renewable energy.“Thanks to many years of structured sustainability work and increased ambitions in our new group-wide sustainability strategy, we have been able to agree on this loan with SEK. It’s very exciting to connect our efforts in sustainability to financing in this manner,” says Malin Ripa, Head of Sustainability, Axel

Agnafit Bidco extends the acceptance period for the public offer to the shareholders of Sobi and announces its intention not to increase the price of SEK 235 per share in the Offer

This announcement is not an offer, whether directly or indirectly, in Australia, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled "Important information" at the end of this announcement and in

Realfiction Holding AB announces its Q3 Interim Report for July – September 2021

The company announces that the Q3 Interim Report for July – September 2021 is now available. The full report is attached as a separate document and can also be downloaded from the company’s website (www.realfiction.com). A printed copy can be ordered via investor@realfiction.com. Below is a brief summary of the Q3 Interim Report.Important key figures:• 329% increase in total revenue Q3, 2021 compared to Q3, 2020• 332% increase in gross profit in Q3, 2021 compared to Q3, 2020• Slightly increased gross profit margin of 55.9% in Q3, 2021 compared to 55.5% in Q3, 2020• Cash-based net

Aker Carbon Capture ASA: third-quarter results 2021

Aker Carbon Capture made good progress with new and existing projects in the third quarter, as the pure-play carbon capture specialist continued its international expansion."We see clear signs of acceleration across the carbon capture market worldwide, and we continue to position our company to be a leading player in this important and fast-growing industry," said Valborg Lundegaard, Chief Executive Officer of Aker Carbon Capture. Highlights in the third quarter included progress made in the Brevik CCS project and securing a number of agreements with new customers in the company's

Ratos AB: Improved earnings in the companies, strong order intake and new acquisitions

Q3 2021Performance Ratos Group · Adjusted[1)] operating profit from continuing operations amounted to SEK 356m (318) · Adjusted[1)] profit for the period amounted to SEK 208m (119) · Profit for the period was impacted by an unrealized loss of SEK 149m related to the revaluation of shares in Dun & Bradstreet Holding Inc. · Operating profit from continuing operations amounted to SEK 208m (318) · Profit for the period amounted to SEK 60m (119) · Diluted earnings per share amounted to SEK 0.04 (0.31) Performance Ratos business group, adjusted for Ratos’s holdings ·

There are no items matching the current filter
There are no more items matching the current filter
Back to top